New Strategies in Rectal Cancer

Area of Science:

• Oncology
• Surgical Oncology
• Gastroenterology

Background:

• Rectal cancer treatment has evolved, particularly regarding locally advanced disease response to neoadjuvant chemoradiation.
• Understanding treatment response has driven innovations in rectal cancer management.
• Current strategies balance oncologic control with functional outcomes.

Purpose of the Study:

• To review contemporary strategies for rectal cancer therapy.
• To highlight organ-preserving and minimally invasive surgical approaches.
• To discuss the role of these strategies in the context of preoperative multimodality treatment.

Main Methods:

• Review of current literature and treatment guidelines for rectal cancer.
• Discussion of organ-preserving strategies such as Watch and Wait.
• Analysis of minimally invasive surgical techniques including transanal total mesorectal excision.

Main Results:

• Organ-preserving strategies are effective for select patients with complete clinical response after neoadjuvant therapy.
• Minimally invasive approaches, including transanal total mesorectal excision, offer benefits for advanced rectal cancer.
• Preoperative multimodality treatment is crucial for optimizing outcomes with these novel strategies.

Conclusions:

• New rectal cancer therapies focus on tailored treatment based on response to neoadjuvant therapy.
• Watch and Wait and minimally invasive surgery represent significant advances in rectal cancer care.
• These approaches aim to improve quality of life while maintaining oncologic safety.